Dear Members, dear Customers
China-Italy Chamber of Commerce (CICC) asks for your valued opinion about CICC services.
Please fill in the questionnaire.
The China-Italy Chamber of Commerce (CICC), together with its Health Care Working Group (HCWG), is pleased to announce that the exclusive Company Tour at BGI is to be held on 15th January 2026 in Shenzhen.
Why Attend?
Exclusive Behind-the-Scenes Access
Tour BGI’s advanced facilities and see how sustainable practices are built into pioneering genomic and biopharmaceutical work.
Direct Engagement with Industry Leaders
Connect directly with top executives and experts from BGI, leading Italian and global healthcare companies. It’s a unique opportunity to gain firsthand insights, ask questions, and discuss the future of sustainable healthcare.
Event details
Date: 15th January 2026, Thursday
Time: 13:00 – 16:00
Venue: BGI Centre (BGI Headquarters) 华大时空中心(华大集团总部)
Address: BGI Center, Yunhua Road No. 9, Meisha Street, Yantian District, Shenzhen, Guangdong Province | 广东省深圳市盐田区云华路9号华大时空中心
Language: English
Event Fee:
CICC Members: RMB 280
Non-Members: RMB 380
Bus provided from Shenzhen (Luohu) Railway Station to BGI (seats are limited, advance registration required)
Agenda
13:00–13:20 Gathering at Shenzhen (Luohu) Railway Station
13:20–14:00 Shuttle to BGI
14:00–16:00 Guided Headquarter Tour and Q&A
More detailed agenda will come out later.
About BGI
Founded in 1999, BGI is one of the world's leading life science and genomics organizations. BGI's mission is to use genomics to benefit mankind and to be a leader in the era of life sciences. BGI follows a genomics development model of "research, production and application". With businesses in more than 100 countries and regions around the world, BGI has established cooperation and partnerships with thousands of different organizations across multi-disciplinary research areas including medical health, resource conservation and judicial services. At the same time, BGI provides equipment, technical support and solutions for the needs of national economies and people's livelihoods, such as precision medicine and precision health. BGI is committed to applying its genetic and technological achievements to real world settings in order to realize the dream of trans-omics for a better life.